首頁市場股票ResMed Inc - US

交易 ResMed Inc - US - RMD 差價合約

252.74+2.63%
The chart shows the RMD stock price data over the last 1 day, with a current price of 252.74, a high of 247.05, and a low of 242.91.
低點: 242.91高點: 247.05
賣方:
0%
買方:
100%
過往表現並非未來業績的可靠指標
交易條件
類型
該金融市場可進行差價合約交易。
了解更多:差價合約
差價合約
點差0.51
長倉隔夜倉息調整
長倉隔夜倉息調整

保證金。您的投資
$1,000.00
隔夜倉息
來自頭寸全值的費用
-0.022346 %
(-$1.12)

使用杠杆的交易規模(大約值)$5,000.00

來自杠杆的資金 - 美元(大約值)$4,000.00


-0.02235%
短倉隔夜倉息調整
短倉隔夜倉息調整

保證金。您的投資
$1,000.00
隔夜倉息
來自頭寸全值的費用
0.000124 %
($0.01)

使用杠杆的交易規模(大約值)$5,000.00

來自杠杆的資金 - 美元(大約值)$4,000.00


0.00012%
隔夜倉息調整時間22:00 (UTC)
貨幣USD
最低成交量0.1
保證金20.00%
證券交易所United States of America
交易佣金10%
保證止損溢價
保證止損 (GSL) 費用僅在 GSL 被觸發時收取。更多詳情請參閱我們網站的「服務費用」 頁面。
1%

1我們執行交易收取的費用是點差,即買入價和賣出價之間的差額。有關更多資訊,請參閱我們網站上的收費頁面

主要統計數據
前收盤價246.11
開倉247.05
1 年變化16.15%
日區間242.91 - 247.05
ResMed (RMD) is a global leader in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders including sleep disordered breathing (SDB), chronic obstructive pulmonary disease (COPD) and other chronic diseases. SDB includes obstructive sleep apnoea (OSA), and other respiratory disorders that occur during sleep. The company’s products and solutions are designed to improve patient quality of life, reduce the impact of chronic disease and lower healthcare costs as global healthcare systems continue to drive a shift in care from hospitals to the home and lower cost settings. ResMed’s cloud-based software digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes and efficiencies for their customers. ResMed employs about 5,000 employees worldwide, operates in 100 countries and has manufacturing facilities in Australia, France, Singapore and the US. The ResMed share price is available at Capital.com.

最新股票文章